Antibody–Drug Conjugates Reshape Solid Tumor Therapy Amid Safety and Target Challenges
A new review in Holistic Integrative Oncology charts the rapid rise of antibody–drug conjugates in solid tumors while detailing the ...
A new review in Holistic Integrative Oncology charts the rapid rise of antibody–drug conjugates in solid tumors while detailing the ...
A retrospective study of 103 patients with HER2-positive de novo metastatic breast cancer found that those who underwent breast surgery ...
A machine learning model applied to routine CT urography scans can non-invasively predict HER2 status in bladder cancer, potentially guiding ...
A large propensity score-matched study finds that synchronous bilateral breast cancer has distinct biological features but no worse survival than ...
A comprehensive Chinese Medical Journal review led by Professor Feng Wang synthesizes five years of advances in esophageal cancer, highlighting ...
A systematic review of 27 guideline families using AGREE II and AGREE-REX finds that clinical practice guidelines for precision oncology ...
A dual-center study shows that a deep learning radiomics model applied to routine mammograms can noninvasively predict HER2-positive and HER2-low ...
A multicenter real-world study found that first-line trastuzumab deruxtecan doubled progression-free survival compared with chemotherapy in HER2-altered advanced NSCLC, while ...
A new review maps the engineering strategies, from dual-target receptors to tumor microenvironment remodeling, that could finally bring CAR-T cell ...
A Brazilian study found that an AI model's measure of HER2 staining heterogeneity within breast cancer samples predicts where pathologists ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine